Geode Capital Management, LLC Medicinova Inc Transaction History

Geode Capital Management, LLC

  • $1.52 Trillion
  • Q3 2025

A detailed history of Geode Capital Management, LLC transactions in Medicinova Inc stock. As of the latest transaction made, Geode Capital Management, LLC holds 529,702 shares of MNOV stock, worth $810,444. This represents 0.0% of its overall portfolio holdings.

Number of Shares
529,702
Previous 525,892 0.72%
Holding current value
$810,444
Previous $688,000 3.05%
% of portfolio
0.0%
Previous 0.0%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025
BUY
$1.22 - $1.45 $4,648 - $5,524
3,810 Added 0.72%
529,702 $667,000
Q2 2025

Aug 08, 2025
SELL
$1.2 - $1.56 $1,328 - $1,726
-1,107 Reduced 0.21%
525,892 $688,000
Q1 2025

May 13, 2025
BUY
$1.46 - $2.16 $17,644 - $26,103
12,085 Added 2.35%
526,999 $769,000
Q4 2024

Feb 12, 2025
BUY
$1.53 - $2.38 $13,690 - $21,296
8,948 Added 1.77%
514,914 $1.08 Million
Q3 2024

Nov 12, 2024
BUY
$1.13 - $2.1 $53,337 - $99,122
47,201 Added 10.29%
505,966 $1.06 Million
Q2 2024

Aug 09, 2024
BUY
$1.28 - $1.57 $26,758 - $32,820
20,905 Added 4.77%
458,765 $660,000
Q1 2024

May 13, 2024
BUY
$1.28 - $1.65 $2,722 - $3,509
2,127 Added 0.49%
437,860 $634,000
Q3 2023

Nov 13, 2023
SELL
$2.01 - $2.6 $3,043 - $3,936
-1,514 Reduced 0.35%
435,733 $910,000
Q4 2022

Feb 13, 2023
BUY
$1.97 - $2.66 $8,616 - $11,634
4,374 Added 1.01%
437,247 $896,000
Q3 2022

Nov 14, 2022
BUY
$2.1 - $2.6 $5,247 - $6,497
2,499 Added 0.58%
432,873 $939,000
Q2 2022

Aug 12, 2022
SELL
$2.31 - $3.14 $48,824 - $66,367
-21,136 Reduced 4.68%
430,374 $1.09 Million
Q1 2022

May 13, 2022
BUY
$2.19 - $2.81 $1,848 - $2,371
844 Added 0.19%
451,510 $1.21 Million
Q4 2021

Feb 11, 2022
BUY
$2.61 - $4.42 $33,629 - $56,951
12,885 Added 2.94%
450,666 $1.21 Million
Q3 2021

Nov 12, 2021
BUY
$3.4 - $4.24 $210,619 - $262,655
61,947 Added 16.48%
437,781 $1.66 Million
Q2 2021

Aug 13, 2021
SELL
$3.76 - $5.14 $1.22 Million - $1.67 Million
-325,794 Reduced 46.43%
375,834 $1.6 Million
Q1 2021

May 12, 2021
BUY
$4.81 - $8.74 $328,494 - $596,889
68,294 Added 10.78%
701,628 $3.54 Million
Q4 2020

Feb 12, 2021
BUY
$5.03 - $6.31 $131,373 - $164,804
26,118 Added 4.3%
633,334 $3.33 Million
Q3 2020

Nov 13, 2020
BUY
$4.67 - $11.0 $80,898 - $190,553
17,323 Added 2.94%
607,216 $3.18 Million
Q2 2020

Aug 13, 2020
BUY
$3.06 - $7.06 $80,410 - $185,522
26,278 Added 4.66%
589,893 $3.2 Million
Q1 2020

May 14, 2020
BUY
$2.9 - $6.97 $66,697 - $160,303
22,999 Added 4.25%
563,615 $2.1 Million
Q4 2019

Feb 13, 2020
BUY
$6.48 - $8.76 $36,482 - $49,318
5,630 Added 1.05%
540,616 $3.64 Million
Q3 2019

Nov 12, 2019
BUY
$7.7 - $10.42 $82,459 - $111,587
10,709 Added 2.04%
534,986 $4.26 Million
Q2 2019

Aug 14, 2019
BUY
$8.29 - $13.22 $762,472 - $1.22 Million
91,975 Added 21.28%
524,277 $5.05 Million
Q1 2019

May 14, 2019
BUY
$6.82 - $10.27 $107,217 - $161,454
15,721 Added 3.77%
432,302 $3.58 Million
Q4 2018

Feb 13, 2019
BUY
$7.65 - $12.83 $186,591 - $312,936
24,391 Added 6.22%
416,581 $3.4 Million
Q3 2018

Nov 13, 2018
BUY
$7.06 - $12.49 $169,898 - $300,571
24,065 Added 6.54%
392,190 $4.9 Million
Q2 2018

Aug 14, 2018
BUY
$7.96 - $13.23 $232,432 - $386,316
29,200 Added 8.62%
368,125 $2.93 Million
Q1 2018

May 15, 2018
BUY
$6.6 - $13.91 $702,992 - $1.48 Million
106,514 Added 45.83%
338,925 $3.46 Million
Q4 2017

Feb 13, 2018
BUY
$5.89 - $7.21 $34,474 - $42,200
5,853 Added 2.58%
232,411 $1.5 Million
Q3 2017

Nov 14, 2017
BUY
$4.43 - $6.58 $21,489 - $31,919
4,851 Added 2.19%
226,558 $1.44 Million
Q2 2017

Aug 14, 2017
BUY
N/A
221,707
221,707 $1.17 Million

Others Institutions Holding MNOV

# of Institutions
25
Shares Held
5.03M
Call Options Held
0
Put Options Held
0
View Full List

About MEDICINOVA INC

MNOV Quotes by TradingView
  • Ticker MNOV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 49,046,200
  • Market Cap $75M
  • Description
  • MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...
More about MNOV
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email